These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6371154)

  • 1. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus.
    Shigeoka AO; Pincus SH; Rote NS; Hill HR
    J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease.
    Hill HR; Kelsey DK; Gonzales LA; Raff HV
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S87-91. PubMed ID: 1728992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.
    Teti G; Calapai M; Calogero G; Tomasello F; Mancuso G; Galli A; Riggio G
    Hybridoma; 1992 Feb; 11(1):13-22. PubMed ID: 1371105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus.
    Ricci ML; von Hunolstein C; Gomez MJ; Parisi L; Tissi L; Orefici G
    J Med Microbiol; 1996 Jun; 44(6):475-81. PubMed ID: 8636965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.
    Hill HR; Shigeoka AO; Augustine NH; Pritchard D; Lundblad JL; Schwartz RS
    J Exp Med; 1984 Jun; 159(6):1618-28. PubMed ID: 6374010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci.
    Hill HR; Gonzales LA; Knappe WA; Fischer GW; Kelsey DK; Raff HV
    J Infect Dis; 1991 Apr; 163(4):792-8. PubMed ID: 2010632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental group B streptococcal infection with hybridoma antibody.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1982 Sep; 37(3):961-5. PubMed ID: 6752032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.
    Raff HV; Siscoe PJ; Wolff EA; Maloney G; Shuford W
    J Exp Med; 1988 Sep; 168(3):905-17. PubMed ID: 3049909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of streptococcal antigens using monoclonal antibodies.
    Harris MC; Polin RA
    Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
    Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
    Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB; Edwards MS; Baker CJ
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner.
    Senn BM; Visram Z; Meinke AL; Neubauer C; Gelbmann D; Sinzinger J; Hanner M; Lundberg U; Boisvert H; Reinscheid D; von Gabain A; Nagy E
    Vaccine; 2011 May; 29(24):4116-24. PubMed ID: 21496467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-protective antibodies against the Ibc proteins of group B streptococci.
    Bevanger L; Naess AI
    Acta Pathol Microbiol Immunol Scand B; 1985 Apr; 93(2):121-4. PubMed ID: 3893032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1.
    Raff HV; Bradley C; Brady W; Donaldson K; Lipsich L; Maloney G; Shuford W; Walls M; Ward P; Wolff E
    J Infect Dis; 1991 Feb; 163(2):346-54. PubMed ID: 1988519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IgG antibodies to carbohydrate and protein antigens in mouse protection tests with group B streptococci.
    Christensen KK; Christensen P; Duc G; Hitzig WH; Lindén V; Müller B; Seger RA
    Pediatr Res; 1984 May; 18(5):478-82. PubMed ID: 6203092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy against group B streptococcal infection in neonatal mice delivered from preimmunized pregnants.
    Itoh T; Yan XJ; Nakano H; Yoshioka M
    Microbiol Immunol; 1986; 30(4):297-305. PubMed ID: 3523166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies.
    Egan ML; Pritchard DG; Dillon HC; Gray BM
    J Exp Med; 1983 Sep; 158(3):1006-11. PubMed ID: 6193228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.